Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nyxol to Reverse Pharmacologically-Induced Mydriasis
NCT05134974Phase 3Completed
- Sponsor
- Opus Genetics
- Start
- Nov 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phentolamine in Mydriasis, sponsored by Opus Genetics. Started Nov 2021; status: completed.
02
Drugs
phentolamine
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT05134974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134974.